fluconazole has been researched along with lactoferrin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, HG; Eikelboom, MC; Kuipers, ME; Meijer, DK; Swart, PJ | 1 |
| Lupetti, A; Nibbering, PH; Paulusma-Annema, A; Senesi, S; van Dissel, JT; Welling, MM | 1 |
| Masci, JR | 1 |
| Lupetti, A; Mazzi, U; Nibbering, PH; Pauwels, EK; Welling, MM | 1 |
| Anil, S; Samaranayake, LP | 1 |
| Brouwer, CP; Dogterom-Ballering, H; Lupetti, A; Nibbering, PH; Paulusma-Annema, A; Senesi, S; Van Dissel, JT; Welling, MM | 1 |
| Chen, J; Fowler, RS; Martinez, C; Naidu, AS; Tulpinski, J | 1 |
| Bogaards, SJ; Brouwer, CP; Campa, M; de Heer, E; Friesen, RH; Lupetti, A; Nibbering, PH; van Dissel, JT; Welling, MM | 1 |
| Campa, M; de Boer, MG; Erba, P; Lupetti, A; Nibbering, PH | 1 |
| Decembrino, L; Farina, D; Franco, C; Gallo, E; Lanari, M; Manzoni, P; Rizzollo, S; Spera, AM; Stronati, M; Tarnow-Mordi, W | 1 |
| Decembrino, L; Farina, D; Franco, C; Gallo, E; Manzoni, P; Mostert, M; Rizzollo, S; Stronati, M | 1 |
| Manzoni, P; Mostert, M; Stronati, M | 1 |
| Izumikawa, K; Kakeya, H; Kobayashi, T; Kohno, S; Miyazaki, T; Ohno, H; Tashiro, T; Yamamoto, Y; Yanagihara, K | 1 |
| Boano, E; Castagnola, E; De Luca, D; Farina, D; Jacqz-Aigrain, E; Luparia, M; Manzoni, P; Mostert, M; Ruffinazzi, G; Stronati, M; Tavella, E | 1 |
| Camacho-Gonzalez, A; Spearman, PW; Stoll, BJ | 1 |
| Anjos, CAD; Curvelo, JAR; Moraes, DC; Portela, MB; Soares, RMA | 1 |
| Dȩbowski, D; Gitlin-Domagalska, A; Gucwa, K; Milewski, S; Okońska, J; Olkiewicz, K; Ptaszyńska, N; Rolka, K; Ruczyński, J; Łȩgowska, A | 1 |
5 review(s) available for fluconazole and lactoferrin
| Article | Year |
|---|---|
Radiotracers for fungal infection imaging.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Chitin; Diagnosis, Differential; Fluconazole; Humans; Lactoferrin; Mice; Peptide Fragments; Radioactive Tracers; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium | 2011 |
Clinical use of lactoferrin in preterm neonates: an update.
Topics: Age of Onset; Animals; Bacterial Infections; Bacterial Translocation; Cattle; Fluconazole; Humans; Incidence; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lactoferrin; Mice; Mycoses; Probiotics; Randomized Controlled Trials as Topic; Risk Factors; Sepsis | 2010 |
Lactoferrin for prevention of neonatal infections.
Topics: Anti-Infective Agents; Chemoprevention; Enterocolitis, Necrotizing; Fluconazole; Humans; Infant, Newborn; Lactoferrin; Premature Birth; Probiotics; Randomized Controlled Trials as Topic; Sepsis | 2011 |
Prevention of nosocomial infections in neonatal intensive care units.
Topics: Anti-Infective Agents; Central Venous Catheters; Contraindications; Cross Infection; Fluconazole; Histamine H2 Antagonists; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Lactoferrin; Milk, Human; Nystatin; Pneumonia, Ventilator-Associated; Probiotics; Sepsis | 2013 |
Neonatal infectious diseases: evaluation of neonatal sepsis.
Topics: Adaptive Immunity; Anti-Infective Agents; Antibodies, Monoclonal; Antifungal Agents; Bacterial Infections; Biomarkers; Blood Cell Count; C-Reactive Protein; Candidiasis; Escherichia coli Infections; Fluconazole; Genomics; Humans; Immunity, Innate; Immunoglobulins, Intravenous; Infant, Newborn; Infant, Newborn, Diseases; Lactoferrin; Polymerase Chain Reaction; Predictive Value of Tests; Proteomics; Risk Factors; Sepsis; Streptococcal Infections; Streptococcus agalactiae | 2013 |
12 other study(ies) available for fluconazole and lactoferrin
| Article | Year |
|---|---|
Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Synergism; Fluconazole; Flucytosine; Humans; Lactoferrin; Microbial Sensitivity Tests | 1999 |
Candidacidal activities of human lactoferrin peptides derived from the N terminus.
Topics: Adenosine Triphosphate; Antifungal Agents; Binding Sites; Candida albicans; Cell Membrane Permeability; Colony-Forming Units Assay; Drug Interactions; Drug Resistance, Microbial; Enzyme Inhibitors; Fluconazole; Humans; Intracellular Membranes; Lactoferrin; Mitochondria; Peptides; Protein Conformation; Sodium Azide; Technetium | 2000 |
Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Female; Fluconazole; Humans; Itraconazole; Lactoferrin; Mouthwashes; Muramidase | 2000 |
Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Candidiasis; Diagnosis, Differential; Fluconazole; Humans; Immunoglobulin G; Inflammation; Lactoferrin; Leukopenia; Lipopolysaccharides; Male; Mice; Myositis; Peptide Fragments; Radionuclide Imaging; Reproducibility of Results; Ribosomal Proteins; Sensitivity and Specificity; Technetium; Thigh; Tissue Distribution | 2002 |
Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole.
Topics: Amphotericin B; Analysis of Variance; Anti-Infective Agents; Antifungal Agents; Candida albicans; Candida tropicalis; Colony Count, Microbial; Fluconazole; Humans; Lactoferrin; Microbial Sensitivity Tests; Mouth; Muramidase; Nystatin; Species Specificity; Statistics as Topic | 2002 |
Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species.
Topics: Candida; Dose-Response Relationship, Drug; Drug Synergism; Fluconazole; Lactoferrin; Peptide Fragments | 2003 |
Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
Topics: Analysis of Variance; Antifungal Agents; Candida albicans; Candida glabrata; Drug Interactions; Female; Fluconazole; Humans; In Vitro Techniques; Lactoferrin; Microbial Sensitivity Tests; Probability; Sensitivity and Specificity; Vaginitis | 2004 |
Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Carrier Proteins; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Fluconazole; Humans; Interleukin-10; Kidney Diseases; Lactoferrin; Mice; Neutropenia; Specific Pathogen-Free Organisms | 2007 |
[Recent advances in prevention of sepsis in the preterm neonate].
Topics: Antifungal Agents; Fluconazole; Humans; Infant, Newborn; Infant, Premature, Diseases; Lactoferrin; Probiotics; Sepsis | 2010 |
Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Invasive; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Iron; Itraconazole; Lactoferrin; Microbial Sensitivity Tests | 2011 |
Histatin 5 and human lactoferrin inhibit biofilm formation of a fluconazole resistant Candida albicans clinical isolate.
Topics: Antifungal Agents; Biofilms; Candida albicans; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazole; Histatins; Humans; Lactoferrin; Microbial Sensitivity Tests; Microscopy, Confocal; Reference Values; Reproducibility of Results | 2019 |
Antibiotic-Based Conjugates Containing Antimicrobial HLopt2 Peptide: Design, Synthesis, Antimicrobial and Cytotoxic Activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Ciprofloxacin; Drug Stability; Escherichia coli; Fluconazole; HEK293 Cells; Hep G2 Cells; Humans; Immunoconjugates; Lactoferrin; Levofloxacin; Male; Microbial Sensitivity Tests; Peptide Fragments; Staphylococcus aureus; Swine | 2019 |